Anxiety and Related Sleep Disorders - Malta

Revenue in the Anxiety and Related Sleep Disorders market is projected to reach US$5.42m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 2.81%, resulting in a market volume of US$6.22m by 2029.
In global comparison, most revenue will be generated United States (US$3.21bn in 2024).
In relation to total population figures, per person revenues of US$115.80 are generated in 2024.

The Anxiety and Related Sleep Disorders market covers sales of three drug classes: anxiolytics, hypnotics, and sedatives. These classes contain different types of drugs, such as benzodiazepines, anticonvulsants, and antihistamines, that reduce anxiety and insomnia symptoms caused by anxiety. These medications mainly fall into the category of prescription drugs.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Pfizer, Bristol-Myers Squibb, GlaxoSmithKline PLC, Johnson & Johnson, and Merck & Co.

Pharmaceutical sales and consumption of anxiolytics
Pharmaceutical sales and consumption hypnotics and sedatives

Non-mental health related sleep disorders
Any other anxiety medications
Psychotherapy

The Anxiety and Related Sleep Disorders market in Malta is experiencing steady growth due to increasing customer preferences for alternative and natural remedies, as well as the rising awareness and diagnosis of these conditions.

Customer preferences: Customers in Malta are increasingly seeking alternative and natural remedies to manage anxiety and sleep disorders. This shift in preference is driven by a growing awareness of the potential side effects of conventional medications, as well as a desire for more holistic approaches to health and wellness. As a result, there is a rising demand for herbal supplements, aromatherapy products, and relaxation techniques such as meditation and yoga.

Trends in the market: The market for anxiety and related sleep disorders in Malta is witnessing a rise in the diagnosis and treatment of these conditions. This can be attributed to several factors, including increased awareness and understanding of mental health issues, improved access to healthcare services, and a decrease in the stigma surrounding mental health. As a result, more individuals are seeking professional help and are being prescribed medication or therapy to manage their symptoms.

Local special circumstances: Malta has a unique demographic profile that contributes to the development of the anxiety and sleep disorders market. The country has a high population density, which can lead to increased stress levels and difficulty in getting quality sleep. Additionally, Malta is a popular tourist destination, and the influx of visitors can contribute to a higher prevalence of anxiety and sleep disorders among both locals and tourists.

Underlying macroeconomic factors: The growth of the Anxiety and Related Sleep Disorders market in Malta is also influenced by underlying macroeconomic factors. The country has experienced steady economic growth in recent years, leading to an increase in disposable income and healthcare spending. As a result, individuals are more willing and able to invest in their mental health and seek treatment for anxiety and sleep disorders.In conclusion, the Anxiety and Related Sleep Disorders market in Malta is developing due to increasing customer preferences for alternative and natural remedies, the rising awareness and diagnosis of these conditions, as well as underlying macroeconomic factors. As customers continue to prioritize their mental health and well-being, the market is expected to further expand in the coming years.

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.